Literature DB >> 27717618

miR-21 promotes collagen production in keloid via Smad7.

Renpeng Zhou1, Chen Wang1, Congji Wen2, Danru Wang3.   

Abstract

OBJECTIVE: To explore the biological function of miR-21 in the formation of keloid.
METHODS: Normal skin and keloid tissue samples underwent histopathologic study and qPCR analysis. The expression of miR-21 and mRNA expression of Smad7, Col1A1, Col3A1 in fibroblasts derived from keloid tissue and normal skin tissue samples were detected by qPCR. Normal and keloid fibroblasts were transfected with miR-21 mimics or inhibitor respectively, and expression of Smad7, Col1A1 and Col3A1 were examined. After the normal fibroblasts were transfected with Smad7 siRNA, expression of Col1A1 and Col3A1 were detected by Western blot and qPCR analysis.
RESULTS: Collagen was obviously thick and disorganized in keloid tissue. The expression of miR-21, Col1A1 and Col3A1 in keloid tissue and keloid-derived fibroblasts were higher than that of normal counterparts, while the expression of Smad7 in keloid tissue and keloid-derived fibroblasts was lower. miR-21 mimics attenuated expression of Smad7, and enhanced the expression of Col1A1, Col3A1. Furthermore, the Smad7 siRNA increased expression of Col1A1and Col3A1.
CONCLUSIONS: miR-21 promoted collagen production in keloid by negatively regulating the expression of the Smad7.
Copyright © 2016 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Extracellular matrix; Keloid; Smad7; miR-21

Mesh:

Substances:

Year:  2016        PMID: 27717618     DOI: 10.1016/j.burns.2016.09.013

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  9 in total

Review 1.  MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.

Authors:  Yan Li; Juan Zhang; Yuying Lei; Lechun Lyu; Ruiling Zuo; Ting Chen
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

Review 2.  Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside.

Authors:  Long-Yuan Zhou; Si-Nan Lin; Florian Rieder; Min-Hu Chen; Sheng-Hong Zhang; Ren Mao
Journal:  Inflamm Bowel Dis       Date:  2021-06-15       Impact factor: 7.290

Review 3.  Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.

Authors:  Ho Jun Lee; Yong Ju Jang
Journal:  Int J Mol Sci       Date:  2018-03-02       Impact factor: 5.923

4.  Eupatilin Inhibits Renal Cancer Growth by Downregulating MicroRNA-21 through the Activation of YAP1.

Authors:  Weifeng Zhong; Zhiming Wu; Nanhui Chen; Kaihua Zhong; Yifeng Lin; Huiming Jiang; Pei Wan; Shanming Lu; Lawei Yang; Siping Liu
Journal:  Biomed Res Int       Date:  2019-04-24       Impact factor: 3.411

5.  Downregulation of CR6-interacting factor 1 suppresses keloid fibroblast growth via the TGF-β/Smad signaling pathway.

Authors:  Harsha Nagar; Sungmin Kim; Ikjun Lee; Seonhee Kim; Su-Jeong Choi; Shuyu Piao; Byeong Hwa Jeon; Sang-Ha Oh; Cuk-Seong Kim
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

6.  Chitosan/Hyaluronic Acid/MicroRNA-21 Nanoparticle-Coated Smooth Titanium Surfaces Promote the Functionality of Human Gingival Fibroblasts.

Authors:  Zhongshan Wang; Guangsheng Wu; Zhujun Yang; Xuejian Li; Zhihong Feng; Yimin Zhao
Journal:  Int J Nanomedicine       Date:  2022-09-01

Review 7.  Targeting Myocardial Fibrosis-A Magic Pill in Cardiovascular Medicine?

Authors:  Alina Scridon; Alkora Ioana Balan
Journal:  Pharmaceutics       Date:  2022-07-30       Impact factor: 6.525

Review 8.  Epigenetic modification mechanisms involved in keloid: current status and prospect.

Authors:  Wenchang Lv; Yuping Ren; Kai Hou; Weijie Hu; Yi Yi; Mingchen Xiong; Min Wu; Yiping Wu; Qi Zhang
Journal:  Clin Epigenetics       Date:  2020-11-26       Impact factor: 6.551

Review 9.  Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine.

Authors:  Ellen S Smith; Eric Whitty; Byunghee Yoo; Anna Moore; Lorenzo F Sempere; Zdravka Medarova
Journal:  Cancers (Basel)       Date:  2022-03-21       Impact factor: 6.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.